Table 3 T scores of neuropsychological tests in survivors of bacterial meningitis
Neuropsychological measurePneumococcal patients (n = 79)Meningococcal patients (n = 76)p Value*
P vs MP vs CM vs C
Intelligence
    Visuospatial reasoning (GIT)50.5 (10.9)50.0 (11.4)0.770.780.97
    Verbal reasoning (GIT)50.8 (10.5)51.2 (10.6)0.790.620.45
Attention/executive functioning
    Stroop Colour–Word Card44.1 (13.8)45.9 (11.1)0.390.010.04
    TMT part B40.4 (17.4)45.6 (12.6)0.040.000.05
    Numerical ability (GIT)46.8 (10.4)51.8 (10.5)<0.010.060.31
    Category Fluency50.9 (10.8)48.9 (12.6)0.300.630.55
    Letter Fluency47.4 (10.7)48.1 (7.9)0.670.140.21
    WCST categories48.0 (13.4)46.4 (11.0)0.420.400.07
    WCST errors49.8 (10.8)48.1 (10.5)0.340.920.28
    WCST perseverative errors46.9 (12.2)46.3 (10.2)0.740.110.03
Memory
    RMBT immediate recall50.4 (9.2)50.6 (12.1)0.920.780.73
    RMBT % retained48.5 (13.0)46.3 (13.3)0.330.300.04
    WMS immediate recall47.0 (14.2)48.6 (11.8)0.480.160.46
    WMS % retained45.7 (15.9)51.5 (9.3)<0.010.060.36
    AVLT immediate recall48.2 (10.2)48.8 (10.2)0.720.100.21
    AVLT % retained48.8 (13.6)48.0 (13.0)0.810.660.48
Psychomotor functions
    TMT part A43.0 (14.6)47.7 (11.3)0.030.000.37
    Stroop Word-Card43.9 (14.4)45.6 (13.3)0.460.000.03
    Stroop Colour-Card43.2 (11.1)43.7 (12.3)0.800.000.00
    SRT dominant hand40.6 (18.0)44.8 (13.3)0.120.000.02
    SRT non-dominant hand43.3 (17.2)45.9 (11.2)0.310.020.05
    Two choice reaction time47.2 (17.2)48.4 (12.1)0.650.310.44
Speed score45.3 (8.8)47.5 (6.7)0.08<0.010.06
No of impaired tests2.2 (2.3)1.6 (2.1)0.10<0.01<0.01
  • AVLT, Rey Auditory Verbal Learning Test; GIT, Groningen Intelligence Test; RBMT, Rivermead Behavioural Memory Test; SRT, Simple Reaction Time; TMT, Trail Making Test; WCST, Wisconsin Card Sorting Test; WMS, Wechsler Memory Scale.

  • Values are mean (SD).

  • *Two tailed p value of t test: comparison of pneumococcal (P) and meningococcal (M) patients; comparison of pneumococcal (P) patients and controls (C); comparison of meningococcal (M) patients and controls (C).